TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP!
From Pfizer’s CEO:
“Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ lives, reduce the severity of COVID-19 infections, and eliminate up to nine out of ten hospitalizations.” (See link here.)
Typically we Nerdy Girls shy away from hyperbole, but in this instance the phrase “gamechanger” might just fit! Before we declare a grand slam, however, we’re waiting for a report-out of the full results and further regulatory scrutiny.
Pfizer’s news drops only a few days after the UK regulator approved competitor Merck’s antiviral. A very, very good week on the #treatment front. (Not to mention this week’s #vax4kids news! 😀)
With love,
Your Nerdy Girls
Additional reference:
UK announcement
